Special Guest · 8:00–8:15 AM PT
?
Special guest
Nurse Capital Fund overview; MM Criteria Discussion
Pitches · 8:15–9:30 AM PT
Major Medical Devices, Inc.
Charles Kerr, CEO · charles@majormedicaldevices.com
AxSES is an ultra low profile modular EVAR stent graft and delivery system that enables abdominal aortic and iliac aneurysm repair through a single upper extremity access site, broadening eligibility for patients with challenging femoral anatomy while simplifying the procedure to support same day outpatient treatment.
Round
5 million Undecided @ 12 million
Closed
250000
FDA milestone
FDA Presub/Qsub meeting
FDA timeline
5 years
Other groups in round
Tech Coast Angels, mHub Ventures, Service Provider Capital, Red Bear Ventures
DD package
yes
Traction: Design Freeze, Excellent Pulsatile Fatigue Durability Testing Results, Granted Seminal/Broad Patent, Superior Acute Performance Testing Results, Successful Sheep Study
What they're looking for: Not at this time
Pathmaker Bio
Richard Fekete, CEO · richard@pathmakerbio.com
We are developing a technology in order to sequence, detect and capture proteins without using bespoke instrumentation
Round
4,000,000 Priced Round @ post $16M
Closed
NA
FDA milestone
NA
FDA timeline
NA
Other groups in round
No
DD package
no
Traction: Proof of Concept
What they're looking for: Seeking advisors and potential partners to test prototypes (and be potential early adopters)
AugMend Health
Sacha Moreau, CEO · smoreau@augmend.health
Clinic integrated and supervised AI and VR behavioral health software for intake, monitoring and behavioral support in patients with chronic health issues.
Round
Minimum 2.5 Post-money SAFE @ 14M Post
Closed
75K
FDA milestone
Currently in Phase 1 trials with multiple institutions.
FDA timeline
N/A for MVP.
Other groups in round
Employees, Advisors, F&F
DD package
yes
Traction: LOIs and paid pilots
What they're looking for: Customer introductions in medical centers with a high need for behavioral health support (directors or chairs of departments)